These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8193433)

  • 1. Theophylline disposition in Korean patients with congestive heart failure.
    Jeong CS; Hwang SC; Jones DW; Ryu HS; Sohn K; Sands CD
    Ann Pharmacother; 1994 Mar; 28(3):396-401. PubMed ID: 8193433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
    Powell JR; Vozeh S; Hopewell P; Costello J; Sheiner LB; Riegelman S
    Am Rev Respir Dis; 1978 Aug; 118(2):229-38. PubMed ID: 697173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable.
    Greenberger PA; Cranberg JA; Ganz MA; Hubler GL
    Am J Med; 1991 Jul; 91(1):67-73. PubMed ID: 1858831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of intravenous cimetidine dosage regimens on the disposition of theophylline.
    Gutfeld MB; Welage LS; Walawander CA; Wilton JH; Harrison NJ
    J Clin Pharmacol; 1989 Jul; 29(7):665-9. PubMed ID: 2760260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline pharmacokinetics: effect of continuous versus intermittent cimetidine i.v. infusion.
    Gaska JA; Tietze KJ; Rocci ML; Vlasses PH
    J Clin Pharmacol; 1991 Jul; 31(7):668-72. PubMed ID: 1894763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of congestive heart failure on theophylline disposition.
    Ueno K; Miyai K; Koyama M; Seki T; Kawaguchi Y; Horiuchi Y
    Clin Pharm; 1990 Dec; 9(12):936-7. PubMed ID: 2292175
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit.
    Dager WE; Albertson TE
    Ann Pharmacother; 1992 Oct; 26(10):1287-91. PubMed ID: 1421656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline disposition following parenteral feeding of malnourished patients.
    Cuddy PG; Bealer JF; Lyman EL; Pemberton LB
    Ann Pharmacother; 1993; 27(7-8):846-51. PubMed ID: 8364261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure.
    Jenne JW; Chick TW; Miller BA; Strickland RD
    Am J Hosp Pharm; 1977 Apr; 34(4):408-9. PubMed ID: 860722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline elimination in congestive heart failure.
    Kuntz HD; Straub H; May B
    Klin Wochenschr; 1983 Nov; 61(21):1105-6. PubMed ID: 6645309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):369-75. PubMed ID: 1834592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.